Advos

Morrow & Sheppard LLP has announced a $31.4 million settlement for two clients who suffered severe injuries in a Texas oilfield explosion, underscoring the risks associated with oilfield operations and the critical role of legal representation in securing justice for workplace accident victims.The explosion occurred during ...

Anthony Silard's latest book, 'Love and Suffering', has been released worldwide, offering a deep dive into the complexities of human emotions and their impact on personal development. The book, a finalist for the 2025 International Book Award in Psychology/Mental Health, combines personal narratives, real-life stories, and ...

Since its inception in 1987, Mattingly Concrete, Inc. has become synonymous with quality and reliability in the Indianapolis concrete contracting industry. Specializing in both residential and commercial projects, the company has demonstrated a consistent commitment to excellence, earning it the title of the best contractor...

A recent study conducted as part of a doctoral dissertation at Queen’s University in Canada has found a potential link between cannabis use and enhanced sexual desire, along with reduced anxiety related to sexual activities. This research, based on two separate studies, adds to the growing body of evidence supporting the be...

Janie’s Art Journals, known for its commitment to sustainability through art, has been chosen as the Cultural Arts Desk Representative for the North American Pavilion at the first World Fair US in Chicago. This selection underscores the growing recognition of sustainable practices in the arts and crafts industry. The event,...

Silvercorp Metals Inc. (NYSE American: SVM) (TSX: SVM), a leading Canadian mining company specializing in silver, gold, lead, and zinc production, has announced its most robust fourth-quarter performance to date. The company's fiscal 2025 results, ending in March, showcased significant growth in revenue and operating cash f...

HeartBeam Inc. (NASDAQ: BEAT) is making strides in the medical technology sector with its development of a groundbreaking solution for at-home detection and monitoring of cardiac conditions. The company's vision to redefine cardiac care by enabling early detection and proactive monitoring outside traditional medical setting...

SEGG Media Corporation, previously known as Lottery.com Inc., has announced its rebranding and strategic overhaul, transitioning into a global sports, entertainment, and ethical gaming conglomerate. This significant shift is underscored by the company's new trading ticker, SEGG, and its operation across three key verticals:...

SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) has reached a pivotal moment with its 7.2 MW Hoadley Hill Road ground-mount solar project in upstate New York, following the successful completion of the Coordinated Electric System Interconnection Review (CESIR). This regulatory approval marks a critical step ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) has taken a significant step forward in the development of its multiple sclerosis (MS) treatment by submitting its drug candidate, Lucid-21-302 (Lucid-MS), to the UK's Innovative Licensing and Access Pathway (ILAP) Passport program. This move underscores the company's commitment to acce...

Calidi Biotherapeutics Inc. (NYSE American: CLDI) has been featured in a recent editorial highlighting its innovative precision genetic medicine platform. This platform is designed to target both primary and metastatic cancer tumors using engineered viruses, offering a novel approach in the fight against cancer. With global...

SKYX Platforms Corp. (NASDAQ: SKYX), a pioneer in smart home technology, has entered into a global sales and marketing agreement with Parrot Uncle, a renowned ceiling fan manufacturer. This partnership is set to launch SKYX's innovative all-in-one smart ceiling fan equipped with a built-in heater, targeting both residential...

Quantum BioPharma Ltd. (NASDAQ: QNTM) has taken a significant step forward in the development of its multiple sclerosis (MS) treatment by submitting its drug candidate, Lucid-MS, to the UK's Innovative Licensing and Access Pathway (ILAP) program. This move is part of the company's global strategy to expedite the clinical ad...

Calidi Biotherapeutics Inc. (NYSE American: CLDI) has recently been featured in a NetworkNewsWire editorial, spotlighting its innovative precision genetic medicine platform. This platform is designed to target both primary and metastatic cancer tumors through the use of engineered viruses, presenting a potential breakthroug...

China's recent restrictions on the export of rare earth metals such as yttrium, samarium, lutetium, gadolinium, dysprosium, terbium, and scandium have raised concerns about the sustainability of Western industries dependent on these materials. The country's leadership in base metals smelting, including copper, steel, and al...

Researchers at the University of Sydney have made a significant breakthrough in the fight against Parkinson's disease, successfully reversing symptoms in mice by targeting a malfunctioning protein. This preclinical study marks the first time such an approach has improved motor function in mice exhibiting symptoms similar to...

The recently passed US Budget Act, under President Donald Trump's administration, has put an immediate stop to federal tax incentives for electric vehicle (EV) buyers, a move that was initially planned to phase out by 2025. This decision marks a significant shift in the government's stance on supporting the EV market, direc...

A recent study conducted by researchers at the Karolinska Institute in partnership with Yale University has demonstrated that artificial intelligence (AI) can significantly improve the accuracy and consistency of skin cancer tissue analysis. This advancement not only enhances the reliability of diagnoses but also provides a...

Calidi Biotherapeutics Inc. (NYSE American: CLDI) has recently been featured in a NetworkNewsWire editorial, spotlighting its innovative precision genetic medicine platform. This platform is designed to target both primary and metastatic cancer tumors through the use of engineered viruses, presenting a potential breakthroug...